Verona Pharma plc
(NASDAQ: VRNA US)
|
4:04 PM UTC, 11/22/24 | |||
---|---|---|---|---|
Last: $38.46 | Change: +0.60 | %Change: +1.58% | Volume: 165,670 |
Open: | $ 38.11 | Volume: | 165,670 | |
---|---|---|---|---|
High: | $ 38.67 | Yield(%) | n/a | |
Low: | $ 37.67 | P/E Ratio (ttm): | n/a | |
Dividend ($): | n/a | Market Cap ($): | n/a | |
EPS ($) | n/a | Shares Out: | n/a |
% Price Change (last 4 weeks): | n/a |
---|---|
% Price Change (last 13 weeks): | n/a |
% Price Change (last 26 weeks): | n/a |
% Price Change (last 52 weeks): | n/a |
% Price Change (year to date): | n/a |
Quick Ratio (x): | n/a |
---|---|
Current Ratio (x): | n/a |
LT Debt/Equity (%): | n/a |
Total Debt/Equity (%): | n/a |
50-day Moving Average: | $n/a |
---|---|
200-day Moving Average: | $n/a |
Avg. Daily Vol. (last 50 days): | n/a |
Avg. Daily Vol. (last 200 days): | n/a |
52-wk high: | $40.13 |
52-wk low: | $11.39 |
Bid: | $38.45 |
Ask: | $38.60 |
Verona Pharma plc
More London Place 3 London SE1 2RE Phone: +44 203 283 4200 Fax: +44 207 863 3314 http://www.veronapharma.com |
Net Operating Cash Flow (n/a ): | n/a |
---|---|
Net Operating Margin (%): | n/a |
Pretax Profit Margin (%): | n/a |
Return on Equity (%): | n/a |
---|---|
Return on Assets (%): | n/a |
Return on Invested Capital (%): | n/a |
Sales/turnover (n/a ): | n/a |
---|---|
Deprec. & Amoritiz (n/a ): | n/a |
Operating Income (n/a ): | n/a |
EPS - Excl. Extraordinary Items: | n/a |